rs151001222
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_144991.3(TSPEAR):c.170G>A(p.Arg57Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 1,605,430 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R57W) has been classified as Likely benign.
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Publications
- ectodermal dysplasia 14, hair/tooth type with or without hypohidrosisInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive nonsyndromic hearing loss 98Inheritance: AR Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSPEAR | ENST00000323084.9 | c.170G>A | p.Arg57Gln | missense_variant | Exon 2 of 12 | 1 | NM_144991.3 | ENSP00000321987.4 | ||
| TSPEAR | ENST00000397916.1 | n.125G>A | non_coding_transcript_exon_variant | Exon 2 of 11 | 1 | |||||
| TSPEAR | ENST00000642437.1 | n.*115G>A | non_coding_transcript_exon_variant | Exon 3 of 13 | ENSP00000496535.1 | |||||
| TSPEAR | ENST00000642437.1 | n.*115G>A | 3_prime_UTR_variant | Exon 3 of 13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.00191 AC: 291AN: 152114Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000545 AC: 134AN: 245710 AF XY: 0.000444 show subpopulations
GnomAD4 exome AF: 0.000242 AC: 351AN: 1453198Hom.: 6 Cov.: 30 AF XY: 0.000237 AC XY: 171AN XY: 722466 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00192 AC: 292AN: 152232Hom.: 1 Cov.: 32 AF XY: 0.00191 AC XY: 142AN XY: 74456 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
- -
- -
- -
- -
Inborn genetic diseases Uncertain:1
The c.170G>A (p.R57Q) alteration is located in exon 2 (coding exon 2) of the TSPEAR gene. This alteration results from a G to A substitution at nucleotide position 170, causing the arginine (R) at amino acid position 57 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
TSPEAR-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Benign:1
Arg57Gln in exon 2 of TSPEAR: This variant is not expected to have clinical sign ificance because it has been identified in 0.6% (26/4406) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs151001222). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at